Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study.

Autor: Jakacki RI, Hamilton M, Gilbertson RJ, Blaney SM, Tersak J, Krailo MD, Ingle AM, Voss SD, Dancey JE, Adamson PC, Jakacki, Regina I, Hamilton, Marta, Gilbertson, Richard J, Blaney, Susan M, Tersak, Jean, Krailo, Mark D, Ingle, Ashish M, Voss, Stephan D, Dancey, Janet E, Adamson, Peter C
Zdroj: Journal of Clinical Oncology; 10/20/2008, Vol. 26 Issue 30, p4921-4927, 7p
Databáze: Supplemental Index